Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Cell Chemical Biology
|
July 28, 2021
A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype
Hafeez S Haniff, Xiaohui Liu, Yuquan Tong, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 10, 2008
Imidazopyridines as VLA-4 integrin antagonists
David J Phillips, Richard J Davenport, Thierry A Demaude, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 2014
Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening
Hongming Chen, Laurent Knerr, Tomas Åkerud, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 23, 2025
Development of novel high-throughput biochemical competition assays to identify ligands of human asialoglycoprotein receptor 1
Jianming Liu, Bradley Peter, Lauren Rhodes, et al.
ACS Medicinal Chemistry Letters
|
October 25, 2016
Discovery of AZD2716: A Novel Secreted Phospholipase A<sub>2</sub> (sPLA<sub>2</sub>) Inhibitor for the Treatment of Coronary Artery Disease
Fabrizio Giordanetto, Daniel Pettersen, Ingemar Starke, et al.
Nature Chemistry
|
August 26, 2020
Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions
Hafeez S Haniff, Laurent Knerr, Xiaohui Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors
Fabrizio Giordanetto, Laurent Knerr, Nidhal Selmi, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 4, 2012
Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor
Fabrizio Giordanetto, Andreas Wållberg, Laurent Knerr, et al.
Journal of Medicinal Chemistry
|
July 1, 2021
Melanocortin 1 Receptor Agonists Based on a Bivalent, Bicyclic Peptide Framework
Thomas Durek, Quentin Kaas, Andrew M White, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2006
2,6-Quinolinyl derivatives as potent VLA-4 antagonists
Marie-Agnès Lassoie, Fabienne Broeders, Philippe Collart, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Cell Chemical Biology
|
July 28, 2021
A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype
Hafeez S Haniff, Xiaohui Liu, Yuquan Tong, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 10, 2008
Imidazopyridines as VLA-4 integrin antagonists
David J Phillips, Richard J Davenport, Thierry A Demaude, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 2014
Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening
Hongming Chen, Laurent Knerr, Tomas Åkerud, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 23, 2025
Development of novel high-throughput biochemical competition assays to identify ligands of human asialoglycoprotein receptor 1
Jianming Liu, Bradley Peter, Lauren Rhodes, et al.
ACS Medicinal Chemistry Letters
|
October 25, 2016
Discovery of AZD2716: A Novel Secreted Phospholipase A<sub>2</sub> (sPLA<sub>2</sub>) Inhibitor for the Treatment of Coronary Artery Disease
Fabrizio Giordanetto, Daniel Pettersen, Ingemar Starke, et al.
Nature Chemistry
|
August 26, 2020
Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions
Hafeez S Haniff, Laurent Knerr, Xiaohui Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors
Fabrizio Giordanetto, Laurent Knerr, Nidhal Selmi, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 4, 2012
Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor
Fabrizio Giordanetto, Andreas Wållberg, Laurent Knerr, et al.
Journal of Medicinal Chemistry
|
July 1, 2021
Melanocortin 1 Receptor Agonists Based on a Bivalent, Bicyclic Peptide Framework
Thomas Durek, Quentin Kaas, Andrew M White, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2006
2,6-Quinolinyl derivatives as potent VLA-4 antagonists
Marie-Agnès Lassoie, Fabienne Broeders, Philippe Collart, et al.
Page
of 4